Annual Current Assets
$416.70 M
-$200.07 M-32.44%
December 31, 2024
Summary
- As of March 1, 2025, TVTX annual total current assets is $416.70 million, with the most recent change of -$200.07 million (-32.44%) on December 31, 2024.
- During the last 3 years, TVTX annual current assets has fallen by -$166.13 million (-28.50%).
- TVTX annual current assets is now -32.44% below its all-time high of $616.77 million, reached on December 31, 2023.
Performance
TVTX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$416.70 M
+$91.96 M+28.32%
December 1, 2024
Summary
- As of March 1, 2025, TVTX quarterly total current assets is $416.70 million, with the most recent change of +$91.96 million (+28.32%) on December 1, 2024.
- Over the past year, TVTX quarterly current assets has dropped by -$200.07 million (-32.44%).
- TVTX quarterly current assets is now -39.28% below its all-time high of $686.23 million, reached on September 30, 2023.
Performance
TVTX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
TVTX Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.4% | -32.4% |
| 3 y3 years | -28.5% | -32.4% |
| 5 y5 years | -2.9% | -32.4% |
TVTX Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.4% | at low | -39.3% | +28.3% |
| 5 y | 5-year | -32.4% | +1.5% | -39.3% | +28.3% |
| alltime | all time | -32.4% | >+9999.0% | -39.3% | >+9999.0% |
Travere Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $177.47 M(+3.1%) | - |
| Dec 2024 | - | $416.70 M(+28.3%) |
| Sep 2024 | - | $324.74 M(-12.0%) |
| Jun 2024 | - | $368.98 M(-23.3%) |
| Mar 2024 | - | $481.08 M(-22.0%) |
| Dec 2023 | $172.19 M(-7.5%) | $616.77 M(-10.1%) |
| Sep 2023 | - | $686.23 M(+26.6%) |
| Jun 2023 | - | $542.05 M(-10.4%) |
| Mar 2023 | - | $604.90 M(+24.4%) |
| Dec 2022 | $186.19 M(-3.9%) | $486.44 M(-9.1%) |
| Sep 2022 | - | $534.84 M(-8.9%) |
| Jun 2022 | - | $586.78 M(-7.0%) |
| Mar 2022 | - | $631.09 M(+8.3%) |
| Dec 2021 | $193.77 M(-1.7%) | $582.83 M(+0.6%) |
| Sep 2021 | - | $579.08 M(+5.3%) |
| Jun 2021 | - | $549.80 M(-2.7%) |
| Mar 2021 | - | $565.04 M(+37.7%) |
| Dec 2020 | $197.03 M(+12.1%) | $410.41 M(-17.5%) |
| Sep 2020 | - | $497.68 M(-1.6%) |
| Jun 2020 | - | $505.56 M(+24.3%) |
| Mar 2020 | - | $406.63 M(-5.2%) |
| Dec 2019 | $175.74 M(-17.7%) | $429.06 M(-2.4%) |
| Sep 2019 | - | $439.72 M(-3.8%) |
| Jun 2019 | - | $457.01 M(-3.9%) |
| Mar 2019 | - | $475.51 M(-4.1%) |
| Dec 2018 | $213.48 M(+9.7%) | $495.68 M(-1.5%) |
| Sep 2018 | - | $502.99 M(+80.3%) |
| Jun 2018 | - | $278.92 M(-2.7%) |
| Mar 2018 | - | $286.80 M(-12.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $194.54 M(+0.8%) | $325.81 M(+0.1%) |
| Sep 2017 | - | $325.34 M(+1.8%) |
| Jun 2017 | - | $319.66 M(-0.8%) |
| Mar 2017 | - | $322.40 M(-3.0%) |
| Dec 2016 | $192.93 M(-8.3%) | $332.35 M(-3.0%) |
| Sep 2016 | - | $342.59 M(+14.1%) |
| Jun 2016 | - | $300.16 M(+0.8%) |
| Mar 2016 | - | $297.74 M(-1.4%) |
| Dec 2015 | $210.33 M(+114.3%) | $301.93 M(+0.7%) |
| Sep 2015 | - | $299.95 M(+22.6%) |
| Jun 2015 | - | $244.74 M(+4.8%) |
| Mar 2015 | - | $233.54 M(+525.6%) |
| Dec 2014 | $98.14 M(+655.0%) | $37.33 M(-17.8%) |
| Sep 2014 | - | $45.44 M(-14.9%) |
| Jun 2014 | - | $53.40 M(+728.8%) |
| Mar 2014 | - | $6.44 M(-14.1%) |
| Dec 2013 | $13.00 M(+451.2%) | $7.50 M(-55.5%) |
| Sep 2013 | - | $16.85 M(+4066.1%) |
| Jun 2013 | - | $404.40 K(-84.7%) |
| Mar 2013 | - | $2.64 M(>+9900.0%) |
| Dec 2012 | $2.36 M(>+9900.0%) | - |
| Nov 2012 | - | $3900.00(0.0%) |
| Aug 2012 | - | $3900.00(0.0%) |
| May 2012 | - | $3900.00(0.0%) |
| Feb 2012 | - | $3900.00(0.0%) |
| Feb 2012 | $0.00(0.0%) | - |
| Nov 2011 | - | $3900.00(0.0%) |
| Aug 2011 | - | $3900.00(-2.5%) |
| Feb 2011 | $0.00 | $4000.00 |
FAQ
- What is Travere Therapeutics annual total current assets?
- What is the all time high annual current assets for Travere Therapeutics?
- What is Travere Therapeutics annual current assets year-on-year change?
- What is Travere Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Travere Therapeutics?
- What is Travere Therapeutics quarterly current assets year-on-year change?
What is Travere Therapeutics annual total current assets?
The current annual current assets of TVTX is $416.70 M
What is the all time high annual current assets for Travere Therapeutics?
Travere Therapeutics all-time high annual total current assets is $616.77 M
What is Travere Therapeutics annual current assets year-on-year change?
Over the past year, TVTX annual total current assets has changed by -$200.07 M (-32.44%)
What is Travere Therapeutics quarterly total current assets?
The current quarterly current assets of TVTX is $416.70 M
What is the all time high quarterly current assets for Travere Therapeutics?
Travere Therapeutics all-time high quarterly total current assets is $686.23 M
What is Travere Therapeutics quarterly current assets year-on-year change?
Over the past year, TVTX quarterly total current assets has changed by -$200.07 M (-32.44%)